| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net increase (decrease) in net assets resulting from operations | 26,019 | 18,917 |
| Purchases of investments | 236,087 | 162,181 |
| Paid-in-kind interest income | 8,197 | 5,280 |
| Increase (decrease) in incentive fees payable | - | -748 |
| Proceeds from sales of investments and principal repayments | 256,683 | 170,684 |
| Net realized (gain) loss on investments and foreign currency transactions | -14,042 | -8,898 |
| Net change in unrealized (appreciation) depreciation on investments and foreign currency translation | -5,000 | 790 |
| Net change in unrealized (appreciation) depreciation on foreign currency forward contracts | -5,005 | -5,977 |
| Amortization of premium and accretion of discount, net | -5,511 | -4,157 |
| Amortization of deferred financing costs | 2,831 | 2,224 |
| (increase) decrease in receivable for unsettled transactions | 4,122 | 13,199 |
| (increase) decrease in interest and dividend receivable | -1,076 | -1,078 |
| (increase) decrease in deferred tax asset | -565 | -523 |
| (increase) decrease in other assets | 1,404 | 1,390 |
| Increase (decrease) in management fees payable | 53 | 9 |
| Increase (decrease) in incentive fees payable | -731 | - |
| Increase (decrease) in interest and other debt financing costs payable | -2,465 | 2,071 |
| Increase (decrease) in deferred tax liability | -565 | -523 |
| Increase (decrease) in accrued expenses and other liabilities | -116 | -805 |
| Net cash provided by (used for) operating activities | 52,076 | 21,308 |
| Issuance of unsecured debt | 115,000 | 115,000 |
| Repurchases of common stock | 333 | - |
| Deferred financing and debt issuance costs paid | 1,065 | 1,065 |
| Distributions paid | 52,248 | 34,838 |
| Borrowings on credit facilities | 293,009 | 211,367 |
| Repayments on credit facilities | 417,991 | 325,041 |
| Net cash provided by (used for) financing activities | -63,628 | -34,577 |
| Effect of exchange rate changes on cash denominated in foreign currency | -67 | -13 |
| Net increase (decrease) in cash, cash equivalents, restricted cash and foreign currency | -11,619 | -13,282 |
| Cash and cash equivalents at beginning of period | 39,422 | - |
| Cash and cash equivalents at end of period | 27,803 | - |
Crescent Capital BDC, Inc. (FCRX)
Crescent Capital BDC, Inc. (FCRX)